
[1] Compared to PARI LC Plus® nebulizer; D Hubert. S Leroy, S Dominique, J Kovarik: Pharmakokinetik comparison of inhaled tobramycin (TOBI®) via PARI eFlow®rapid or PARI LC Plus™ nebulizers in cystic fibrosis patients. European Cystic Fibrosis Society, 30th Cystic Fibrosis Conference, Belek, Antalya-Turkey, 13-16 June 2007
Since 1968, the products in the PARI BOY family have been further developed and continuously improved to benefit patients. All of the advantages of our compressor devices, PARI BOY SX, PARI JuniorBOY SX and PARI TurboBOY SX, at a glance: